24/7 Wall St. on MSN
Forget Hims. Its CEO dumped 436,000 shares before a 1,266% earnings miss. Here is the profitable healthcare stock to own instead
Quick Read Hims & Hers (HIMS) reported Q1 2026 EPS of -$0.40 versus $0.03 consensus, a net loss of $92.11M, gross margin ...
Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS) today announced the pricing of its offering of $350 million aggregate principal amount of 0.00% convertible senior notes due 2032 ...
Hims & Hers Health shares fell nearly 10% on Monday after the telehealth company said it plans to sell $300 million of convertible senior ...
Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...
TechFinancials on MSN
The real 10-year cost of Hims and Keeps: Why some subscribers are now asking about surgery
When Hims launched its men’s wellness platform in 2017 with a stripped-down telehealth model for finasteride and minoxidil, the pitch was disarmingly simple: skip the dermatologist, skip the awkward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results